Jing Du

6PUBLICATIONS
11CO-AUTHORS
Social epidemiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 28, 2025
Socioeconomic disparity in stage at cancer diagnosis among patients with type 2 diabetes in Dutch primary care: a cross-sectional study.

Jing de Haan-Du, Klaas H Groenier, Nanne Kleefstra

|Nov 28, 2022
The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care.

Jing de Haan-Du, Klaas H Groenier, Brendy Wauben-Spaetgens

|Oct 13, 2021
Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-Analysis.

Fan Zhang, Jing de Haan-Du, Grigory Sidorenkov

|Sep 08, 2021
The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study.

Jing de Haan-Du, Gijs W D Landman, Klaas H Groenier

|Jul 02, 2021
Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort Study.

Jing de Haan-Du, Gijs W D Landman, Nanne Kleefstra

|May 15, 2020
Is Gliclazide Associated with a Lower Obesity-Related Cancer Risk Compared to Other Sulfonylureas? A Long-term Prospective Cohort Study.

Jing Du, Nanno Kleefstra, Dennis Schrijnders

Pageof 1

Frequent Collaborators

5 joint publications

Geertruida H de Bock

2 joint publications

Klaas H Groenier

2 joint publications

Gijs W D Landman

2 joint publications

Mathilde Jalving